Evidence map›Paper›PMID 40679316›Full record

ArticleBiology open2025

From Primary Cell to Organoid: the proliferative fate international conference and workshop.

Mohamed Jemaà, Amine Bourzam, Marwen Ben Fdilen, Mariem Sellami

Abstract read
In one paragraph

Article in Biology open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohamed JemaàHuman Genetics Laboratory LR99ES10, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis 1006, Tunisia.ORCID 0000-0003-4905-1020
Amine BourzamNeurophysiology, Cellular Physiopathology and Valorisation of Biomolecules Laboratory LR18ES03, Faculty of Sciences of Tunis, Tunis El Manar University, Tunis 2092, Tunisia.
Marwen Ben FdilenNeurophysiology, Cellular Physiopathology and Valorisation of Biomolecules Laboratory LR18ES03, Faculty of Sciences of Tunis, Tunis El Manar University, Tunis 2092, Tunisia.
Mariem SellamiNeurophysiology, Cellular Physiopathology and Valorisation of Biomolecules Laboratory LR18ES03, Faculty of Sciences of Tunis, Tunis El Manar University, Tunis 2092, Tunisia.

Funding

The Company of Biologists EA1199
6 · The paper itself

Abstract

Cell culture is an essential tool for basic, biomedical and translational research. This can be as routine as growing cell lines for toxicity assays, as specific and personalised as patient-derived cell culture, or it can mimic physiological conditions such as organoid culture. In order to train and promote collaborative research among North African researchers in the field of cell culture, a consortium formed by the Faculty of Sciences of Tunis, Tunisia, the Laboratory of Neurophysiology, Cellular Physiopathology and Valorisation of Biomolecules, the Merck Group and Learn and Win decided to organise a North African conference and workshop on complex cell culture, from primary cells to organoids. For 1 week, from 18 to 23 November 2024, more than 500 young researchers and students in the life sciences and more than 30 international speakers and trainers met at the Faculty of Sciences in Tunis, Tunisia, to discuss cell culture technology and protocols, from primary cell culture to organoids, with a strong focus on technologies and discoveries. This meeting review describes the scientific event and highlights the main results of both the conferences and the practical sessions.

Indexed as

Cell Culture TechniquesOrganoidsAnimalsCell ProliferationCongresses as TopicHumans2D and 3D cultureCell cultureHands-on workshopOrganoidsPrimary cellsSpheroids

Identifiers

PMID40679316
PMCPMC12309900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.